RESILIENCE, COGNITION & LONG-TERM OPTIMIZATION PROTOCOL

Objective
Support high-performing or optimized BHRT patients with improved sleep, cognition, stress resilience, and long-term GH signaling.

2 vials of CJC No DAC + Ipamorelin (5/10mg Blend) pen

2 vials of Epitalon

 

"Direct shipping without issues is only guaranteed within the United States and Mexico. For all other countries, the buyer assumes full responsibility once the shipment is handed over to the courier (FedEx/DHL), including customs clearance and local compliance."

1. Component Analysis

This protocol is designed as a “Maintenance” or “Longevity” stack. It is less aggressive than the fat-loss stack and focuses on sustaining healthy biological rhythms.

  • CJC No DAC + Ipamorelin (Blend):
    • Role: The foundational Growth Hormone Secretagogue.
    • Mechanism: As detailed previously, this mimics the body’s natural pulsatile release of Growth Hormone. In a “cognition and resilience” context, the focus is less on muscle growth and more on the neuroprotective effects of IGF-1 (which increases largely due to GH) and the deep sleep improvements necessary for brain clearance (glymphatic system)..
  • Epitalon (Epithalon):
    • Role: The “Longevity” Peptide.
    • Mechanism: Included here for its ability to regulate the pineal gland, normalize melatonin, and potentially elongate telomeres. It acts as a system-wide “reset” button for biological aging markers.

2. Protocol Breakdown

Core Bundle

  • Target: The “Optimized” patient. Someone who is likely already on Hormone Replacement Therapy (BHRT) and wants to add peptide therapy to slow down aging markers without aggressive changes to their body composition.
  • The Logic: This is a “Sustainability” stack.
    • CJC/Ipamorelin keeps GH levels youthful (which naturally decline with age).
    • Epitalon combats cellular aging (telomeres) and ensures the circadian rhythm supports the GH therapy.

Related products

VISCERAL FAT, SARCOPENIA & METABOLIC OPTIMIZATION PROTOCOL
GLP-1 / GIP + METABOLIC SUPPORT OPTION A